Coutance Guillaume, Saplacan Vladimir, Belin Annette, Repessé Yohann, Buklas Dimitrios, Massetti Massimo
Department of Cardiology, University Hospital Center-Caen, Caen, France.
Asian Cardiovasc Thorac Ann. 2014 Mar;22(3):350-2. doi: 10.1177/0218492312474902. Epub 2013 Aug 16.
We report the case of a 64-year-old Jarvik 2000 recipient with a high risk of bleeding (anticoagulation treatment and acquired von Willebrand disease), who presented with intractable gastrointestinal hemorrhage due to severe gastric angiodysplasia. He was successfully treated with long-acting octreotide.
我们报告了一例64岁的Jarvik 2000植入者,其出血风险高(接受抗凝治疗且患有获得性血管性血友病),因严重胃血管发育异常出现难治性胃肠道出血。他接受长效奥曲肽治疗后获得成功。